Tag: HP-MAP
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Featured Article
Future-ready manufacturing: How AI and cloud ERP are transforming supply chains
As manufacturers face growing supply chain disruption, rising costs and increasing operational complexity, artificial intelligence (AI), cloud ERP and connected digital systems are becoming essential tools for improving visibility, resilience and decision-making.
